Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
Condition(s):MyelomaLast Updated:August 21, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):MyelomaLast Updated:August 21, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:August 9, 2023Active, not recruiting
Condition(s):Non-Hodgkin’s LymphomaLast Updated:December 3, 2012Terminated
Condition(s):Lymphoblastic Leukemia, AcuteLast Updated:September 11, 2020Completed
Condition(s):Brain TumorsLast Updated:April 19, 2022Active, not recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:November 19, 2020Unknown status
Condition(s):Non-Hodgkin’s Lymphoma; Diffuse Large B-Cell Lymphoma; DLBCL; NHLLast Updated:March 22, 2024Recruiting
Condition(s):Follicular LymphomaLast Updated:March 15, 2024Not yet recruiting
Condition(s):Acute Lymphoid Leukemia; Minimal Residual Disease; Gene Abnormality; Chemotherapeutic ToxicityLast Updated:September 8, 2023Recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:May 20, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.